Predictive Ability of Intermittent Daily Sickle Cell Pain Assessment: The PiSCES Project.

about

Predictive Ability of Intermittent Daily Sickle Cell Pain Assessment: The PiSCES Project.

Item

http://www.wikidata.org/entity/Q45070197

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Predictive Ability of Intermittent Daily Sickle Cell Pain Assessment: The PiSCES Project.

@en

Predictive Ability of Intermittent Daily Sickle Cell Pain Assessment: The PiSCES Project.

@nl

type

Item

label

Predictive Ability of Intermittent Daily Sickle Cell Pain Assessment: The PiSCES Project.

@en

Predictive Ability of Intermittent Daily Sickle Cell Pain Assessment: The PiSCES Project.

@nl

prefLabel

Predictive Ability of Intermittent Daily Sickle Cell Pain Assessment: The PiSCES Project.

@en

Predictive Ability of Intermittent Daily Sickle Cell Pain Assessment: The PiSCES Project.

@nl

P1476

Predictive Ability of Intermittent Daily Sickle Cell Pain Assessment: The PiSCES Project

@en

P2093

Bassam Dahman

http://www.w3.org/2001/XMLSchema#string

Donna K McClish

http://www.w3.org/2001/XMLSchema#string

Imoigele Aisiku

http://www.w3.org/2001/XMLSchema#string

James Levenson

http://www.w3.org/2001/XMLSchema#string

John Roberts

http://www.w3.org/2001/XMLSchema#string

Susan Roseff

http://www.w3.org/2001/XMLSchema#string

Viktor E Bovbjerg

http://www.w3.org/2001/XMLSchema#string

Wally R Smith

http://www.w3.org/2001/XMLSchema#string

P2860

The McGill Pain Questionnaire: major properties and scoring methods

Novel Metrics in the Longitudinal Evaluation of Pain Data in Sickle Cell Disease.

Management of sickle cell disease.

One hundred years of sickle cell disease.

Expanding options for developing outcome measures from momentary assessment data.

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.

Daily assessment of pain in adults with sickle cell disease.

Pain, quality of life, and coping in sickle cell disease.

P304

1972-1981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/PM/PNX214

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29036363

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

6176749

http://www.w3.org/2001/XMLSchema#string